ZA98975B - Melanins with improved ability to inhibit hiv replication - Google Patents

Melanins with improved ability to inhibit hiv replication

Info

Publication number
ZA98975B
ZA98975B ZA98975A ZA98975A ZA98975B ZA 98975 B ZA98975 B ZA 98975B ZA 98975 A ZA98975 A ZA 98975A ZA 98975 A ZA98975 A ZA 98975A ZA 98975 B ZA98975 B ZA 98975B
Authority
ZA
South Africa
Prior art keywords
melanins
hiv replication
improved ability
inhibit hiv
inhibit
Prior art date
Application number
ZA98975A
Other languages
English (en)
Inventor
Stephen R Garger Jr
Saul L Neidleman
Original Assignee
Biosource Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosource Tech Inc filed Critical Biosource Tech Inc
Publication of ZA98975B publication Critical patent/ZA98975B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA98975A 1997-02-06 1998-02-06 Melanins with improved ability to inhibit hiv replication ZA98975B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/796,822 US6300057B1 (en) 1997-02-06 1997-02-06 Melanins with improved ability to inhibit HIV replication

Publications (1)

Publication Number Publication Date
ZA98975B true ZA98975B (en) 1998-10-08

Family

ID=25169150

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA98975A ZA98975B (en) 1997-02-06 1998-02-06 Melanins with improved ability to inhibit hiv replication

Country Status (9)

Country Link
US (2) US6300057B1 (fr)
EP (3) EP1014964A1 (fr)
JP (1) JP2001512437A (fr)
KR (1) KR20000070851A (fr)
AU (1) AU730073B2 (fr)
CA (1) CA2280178A1 (fr)
IL (1) IL131233A0 (fr)
WO (1) WO1998034606A1 (fr)
ZA (1) ZA98975B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6300057B1 (en) * 1997-02-06 2001-10-09 Large Scale Biology Corporation Melanins with improved ability to inhibit HIV replication
US20050002962A1 (en) * 2003-04-16 2005-01-06 David Pasco Immunostimulatory agents in botanicals
JP4677601B2 (ja) * 2004-09-30 2011-04-27 泰広 飯田 フローインジェクション分析装置およびフローインジェクション分析方法
US8586090B2 (en) * 2004-10-05 2013-11-19 Albert Einstein College Of Medicine Of Yeshiva University Melanin nanoshells for protection against radiation and electronic pulses
WO2009082735A1 (fr) * 2007-12-21 2009-07-02 University Of Chicago Mélanines synthétisées par voie chimique ou par catalyse enzymatique
EP2474313A1 (fr) * 2011-01-11 2012-07-11 ABRA Pharmaceuticals sàrl Nouveaux dérivés de polymère de polyphénol-quinonoïde auto-assemblés et leur utilisation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5529909A (en) * 1988-02-26 1996-06-25 Biosource Technologies, Inc. Tyrosinase-activator protein fusion enzyme
WO1990012869A1 (fr) * 1989-04-26 1990-11-01 Sloan-Kettering Institute For Cancer Research Cellule eucaryote non melanocytique exprimant de maniere constitutive la tyrosinase humaine biologiquement active, et son utilisation
US5057325A (en) * 1990-03-20 1991-10-15 Vanderbilt University Method of inhibiting replication of HIV with water-soluble melanins
US5157075A (en) 1990-05-02 1992-10-20 Taenaka Mining Co., Ltd. Modified melanin
CA2082952C (fr) 1990-05-14 1997-01-14 Ago B. Ahene Melanines modifiees, de couleur, methodes de preparation et utilisation
JPH06500011A (ja) 1990-06-29 1994-01-06 ラージ　スケール　バイオロジー　コーポレイション 形質転換された微生物によるメラニンの製造
WO1992016189A1 (fr) * 1990-10-25 1992-10-01 Yale University Melanine soluble
ES2027528A6 (es) 1990-12-17 1992-06-01 Andromaco Lab Procedimiento para la obtencion de polimeros con actividad antiviral.
US5340734A (en) * 1992-11-25 1994-08-23 Biosource Genetics Corporation Method for making stable, extracellular tyrosinase and synthesis of polyphenolic polymers therefrom
US5744125A (en) 1993-08-19 1998-04-28 Yale University Cosmetic melanins
US6300057B1 (en) * 1997-02-06 2001-10-09 Large Scale Biology Corporation Melanins with improved ability to inhibit HIV replication

Also Published As

Publication number Publication date
KR20000070851A (ko) 2000-11-25
EP1095652A3 (fr) 2004-03-03
CA2280178A1 (fr) 1998-08-13
US20020039726A1 (en) 2002-04-04
EP1014964A1 (fr) 2000-07-05
JP2001512437A (ja) 2001-08-21
WO1998034606A1 (fr) 1998-08-13
AU730073B2 (en) 2001-02-22
EP1095652A2 (fr) 2001-05-02
US6300057B1 (en) 2001-10-09
US6440691B1 (en) 2002-08-27
IL131233A0 (en) 2001-01-28
EP1096021A2 (fr) 2001-05-02
AU6261698A (en) 1998-08-26
EP1096021A3 (fr) 2004-03-10

Similar Documents

Publication Publication Date Title
PL347586A1 (en) Hiv replication inhibiting pyrimidines
GB9713077D0 (en) Improvements relating to skin prickers
ZA982092B (en) Improvements in or related to disinfectants
GB9708512D0 (en) Improvements relating to skin prickers
GB9726773D0 (en) Improvements in or relating to ultrasonagraphy
IL131233A0 (en) Melanins with improved ability to inhibit hiv replication
GB9701669D0 (en) Improvements to structure
GB2332142B (en) Improvements relating to furniture anchorages
GB2325945B (en) Improvements in or relating to a pannelling arrangement
GB2325956B (en) Improvements in or relating to holding devices
GB9707596D0 (en) Improvements in or relating to stages
GB2338058B (en) Improvements in or relating to fires
GB2321389B (en) Improvements to shelving
GB2322145B (en) Improvements in or relating to a structural arrangement
GB2330323B (en) Improvements in or relating to knives
AU8131598A (en) Utilization of salicylates to increase the bioproductivity in plants
GB9718664D0 (en) Improvements in or relating to capsules
GB9721604D0 (en) Improvements in or relating to chairs
GB9710041D0 (en) Improvements in or relating to furniture
GB9706277D0 (en) Improvements in or relating to construction sets
GB9720509D0 (en) Improvements relating to furniture
GB9612759D0 (en) Improvements relating to pendants
AU1498297A (en) Improvements in or relating to cabinets
GB9819043D0 (en) Improvements in or relating to toilets
GB9725642D0 (en) Improvements in or relating to keyboards or the like